Articles

Results 1 to 5 of 5
Most popular |Most recent


Federal Court upholds Health Canada’s strict interpretation of patent listing deadline for KEYTRUDA formulation patent

Canada - April 27 2021 The Federal Court recently dismissed Merck's application for judicial review of Health Canada's refusal to add Canadian Patent No. 2,830,806 (806…

Federal Court of Appeal upholds Federal Court decision finding Shire’s VYVANSE patent valid

Canada - March 30 2021 The Federal Court of Appeal (FCA) recently dismissed an appeal by Apotex from a decision of the Federal Court (see our article here) holding that the…

Federal Court of Appeal refuses to grant stay of Federal Court decision remanding Health Canada’s refusal of SHINGRIX CSP

Canada - September 28 2020 The Federal Court of Appeal recently dismissed a motion brought by the Minister of Health (the Minister) for stay of a judgment of the Federal Court…

Federal Court dismisses application for judicial review of Health Canada’s refusal to grant NHP licence for BOLUOKE oral lumbrokinase capsules

Canada - June 26 2020 On June 4, 2020 the Federal Court dismissed an application for judicial review brought by Canada RNA Biochemical Inc (C-RNA) of Health Canada's…

Federal Court dismisses Biogen’s actions under PMNOC Regulations against Taro and Pharmascience re: FAMPYRA

Canada - May 29 2020 On May 15, 2020, Manson J. Of the Federal Court dismissed two actions brought by Biogen under the Patented Medicines (Notice of Compliance)…